Suchergebnisse - "Villacampa, G"

PubPharm (22)

1

Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancer

enthalten in: ESMO open | 2024

von Marín-Aguilera, M. | Jares, P. | Sanfeliu, E. | +37

2

Prognostic value of HER2DX in early-stage HER2-positive breast cancer : a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network-Breast dataset (SCAN-B)

enthalten in: ESMO open | 2024

von Villacampa, G. | Pascual, T. | Brasó-Maristany, F. | +17

3

Novel trial designs for patients with gastrointestinal stromal tumor

enthalten in: ESMO open | 2024

von Serrano, C. | Rothschild, S. | Villacampa, G. | +12

4

Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Villacampa, G. | Tung, N. | Pernas, S. | +32

5

Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer : final results from part A of the window-of-opportunity SOLTI TOT-HER3 pre-operative study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Oliveira, M. | Falato, C. | Cejalvo, J. | +25

6

Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Ros, J. | Matito, J. | Villacampa, G. | +17

7

Exploratory analysis of clinical benefit of ipilimumab and nivolumab treatment in patients with metastatic melanoma from a single institution

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2022

von Vila, C. | Moreno, F. | Estébanez, M. | +14

8

Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC) : analysis of the GeparSixto randomized clinical trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Llop-Guevara, A. | Loibl, S. | Villacampa, G. | +18

9

Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC) : analysis of the GeparSixto randomized clinical trial

enthalten in: Annals of oncology | 11 September 2021

von Llop-Guevara, A. | Loibl, S. | Villacampa, G. | +18

10

Exploratory analysis of clinical benefit of ipilimumab and nivolumab treatment in patients with metastatic melanoma from a single institution

enthalten in: Clinical & translational oncology | 2021

von Vila, C. | Moreno, F. | Estébanez, M. | +14